Abstract
Utilizing a structure based design approach, combined with extensive medicinal chemistry execution, highly selective, potent and novel BACE1 inhibitor 8 (BACE1 Alpha assay IC50=8nM) was made from a weak μM potency hit in an extremely efficient way. The detailed SAR and general design approaches will be discussed.
Copyright © 2013 Elsevier Ltd. All rights reserved.
MeSH terms
-
Amyloid Precursor Protein Secretases / antagonists & inhibitors*
-
Amyloid Precursor Protein Secretases / metabolism
-
Aspartic Acid Endopeptidases / antagonists & inhibitors*
-
Aspartic Acid Endopeptidases / metabolism
-
Dose-Response Relationship, Drug
-
Drug Design*
-
Humans
-
Isoquinolines / chemistry
-
Isoquinolines / pharmacology*
-
Models, Molecular
-
Molecular Structure
-
Protease Inhibitors / chemical synthesis*
-
Protease Inhibitors / chemistry
-
Protease Inhibitors / pharmacology*
-
Structure-Activity Relationship
-
Thiophenes / chemistry
-
Thiophenes / pharmacology*
Substances
-
G 1617
-
Isoquinolines
-
Protease Inhibitors
-
Thiophenes
-
Amyloid Precursor Protein Secretases
-
Aspartic Acid Endopeptidases
-
BACE1 protein, human